CAM
IHI icon

Concorde Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Concorde Asset Management’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-86,834
Closed -$4.21M – 166
2023
Q3 		$4.21M Sell
86,834
-4,238
-5% -$225K 3.79% 5
2023
Q2 		$5.14M Buy
91,072
+4,121
+5% +$227K 4.74% 5
2023
Q1 		$4.69M Buy
+86,951
New +$4.63M 5.56% 3
2022
Q1 		– Sell
-21,869
Closed -$1.44M – 178
2021
Q4 		$1.44M Sell
21,869
-865
-4% -$55.4K 0.86% 34
2021
Q3 		$1.43M Buy
22,734
+17,976
+378% +$1.15M 0.82% 30
2021
Q2 		$286K Sell
4,758
-43,224
-90% -$2.5M 0.16% 137
2021
Q1 		$2.64M Sell
47,982
-41,976
-47% -$2.33M 1.52% 10
2020
Q4 		$4.91M Buy
89,958
+20,256
+29% +$1.06M 2.73% 7
2020
Q3 		$3.48M Buy
69,702
+20,388
+41% +$987K 1.99% 9
2020
Q2 		$2.18M Buy
49,314
+35,304
+252% +$1.51M 1.82% 13
2020
Q1 		$526K Sell
14,010
-137,442
-91% -$5.79M 0.54% 46
2019
Q4 		$6.67M Buy
151,452
+2,664
+2% +$112K 4.62% 3
2019
Q3 		$6.13M Sell
148,788
-6,648
-4% -$272K 4.72% 3
2019
Q2 		$6.24M Sell
155,436
-5,838
-4% -$221K 3.65% 2
2019
Q1 		$6.22M Sell
161,274
-2,868
-2% -$104K 4.02% 2
2018
Q4 		$5.47M Buy
164,142
+26,268
+19% +$910K 4.63% 2
2018
Q3 		$5.23M Sell
137,874
-12,648
-8% -$449K 5.1% 2
2018
Q2 		$5.03M Sell
150,522
-6,726
-4% -$219K 5.75% 2
2018
Q1 		$4.88M Buy
157,248
+2,220
+1% +$68.4K 5.97% 2
2017
Q4 		$4.48M Sell
155,028
-201,480
-57% -$5.81M 5.67% 2
2017
Q3 		$9.92M Buy
356,508
+192,348
+117% +$5.32M 8.59% 1
2017
Q2 		$4.56M Buy
164,160
+59,616
+57% +$1.58M 6.15% 1
2017
Q1 		$2.64M Buy
+104,544
New +$2.53M 4.35% 1

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Concorde Asset Management's IHI Position: Q4 2023 in Review

Concorde Asset Management sold out of iShares US Medical Devices ETF (IHI) in Q4 2023, closing a stake of 86,834 shares — an estimated $4.21M sold.

Concorde Asset Management first reported a position in IHI in Q1 2017 and held it in 23 quarters. The position peaked at $9.92M in Q3 2017. 576 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

  • Concorde Asset Management reported no remaining iShares US Medical Devices ETF position as of Q4 2023 after selling out during the quarter.
  • Concorde Asset Management sold 86,834 iShares US Medical Devices ETF shares in Q4 2023, an estimated $4.21M.
  • Concorde Asset Management first reported a position in iShares US Medical Devices ETF in Q1 2017 and held it in 23 quarters.
  • Concorde Asset Management's iShares US Medical Devices ETF position peaked at $9.92M in Q3 2017.
  • 576 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on Concorde Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.